Disorders of the fetomaternal unit

Neonatal Hematology

Volumn , Issue , 2005, Pages 10-39

  Werner, Eric J ^a  

^a Children's Hospital of The King's Daughters   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84922602920     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511545306.004     Document Type: Chapter

References (261)

1. Wardrop, C. A., Holland, B. M. The roles and vital importance of placental blood to the newborn infant. J Perinat Med 1995; 23:139-143.
2. Crane, J. M., van den Hof, M. C., Dodds, L., Armson, B. A., Liston, R. Neonatal outcomes with placenta previa. Obstet Gynecol 1999; 93:541-544.
3. Faxelius, G., Raye, J., Gutberlet, R., et al. Red cell volume measurements and acute blood loss in high-risk newborn infants. JPediatr 1977; 90:273-281.
4. McShane, P. M., Heyl, P. S., Epstein, M. F. Maternal and perinatal morbidity resulting from placenta previa. Obstet Gynecol 1985; 65:176-182.
5. Linderkamp, O., Versmold, H. T., Strohhacker, I., et al. Capillary-venous hematocrit differences in newborn infants. I. Relationship to blood volume, peripheral blood flow, and acid base parameters. Eur J Pediatr 1977; 127: 9-14.
6. Jorgensen, J. Feto-maternal bleeding. During pregnancy and at delivery. Acta Obstet Gynecol Scand 1977; 56: 487-490.
7. Sebring, E. S., Polesky, H. F. Fetomaternal hemorrhage: incidence, risk factors, time of occurrence, and clinical effects. Transfusion 1990; 30: 344-357.
8. Laube, D. W., Schauberger, C. W. Fetomaternalbleeding as a cause for unexplained fetal death. Obstet Gynecol 1982; 60: 649-651.
9. Catalano, P. M., Capeless, E. L. Fetomaternal bleeding as a cause of recurrent fetal morbidity and mortality. Obstet Gynecol 1990; 76: 972-973.
10. Downing, G. J., Kilbride, H. W., Yeast, J. D. Nonimmune hydrops fetalis caused by a massive fetomaternal hemorrhage associated with elevated maternal serum alpha- fetoprotein levels: a case report. J Reprod Med 1990; 35: 444-446.
11. Duckett, J. R., Constantine, G. The Kleihauer technique: an accurate method of quantifying fetomaternal haemorrhage? Br J Obstet Gynaecol 1997; 104: 845-846.
12. Davis, B. H., Olsen, S., Bigelow, N. C., Chen, J. C. Detection of fetal red cells in fetomaternal hemorrhage using a fetal hemoglobin monoclonal antibody by flow cytometry. Transfusion 1998; 38: 749-756.
13. Alter, B. P, Weiner, M. A., Harris, M. B. Erythrocyte characteristics in childhood acute leukemia. Am J PediatrHematol Oncol 1989; 11:8-15.
14. Whitecar, P. W., Moise, K. J., Jr. Sonographic methods to detect fetal anemia in red blood cell alloimmunization. Obstet Gynecol Surv 2000; 55: 240-250.
15. Tsuda, H., Matsumoto, M., Sutoh, Y., etal. Massive fetoma- ternal hemorrhage. Int J Gynaecol Obstet 1995; 50:47-49.
16. Dickinson, J. E., Evans, S. F. Obstetric and perinatal outcomes from the Australian and New Zealand Twin-Twin Transfusion Syndrome Registry. Am J Obstet Gynecol 2000; 182:706-712.
17. Fries, M. H., Goldstein, R. B., Kilpatrick, S. J., et al. The role of velamentous cord insertion in the etiology of twin-twin transfusion syndrome. Obstet Gynecol 1993; 81: 569-574.
18. Blickstein, I. The twin-twin transfusion syndrome. Obstet Gynecol 1990; 76: 714-722.
19. Wenstrom, K. D., Tessen, J. A., Zlatnik, F. J., Sipes, S. L. Frequency, distribution, and theoretical mechanisms of hematologic and weight discordance in monochorionic twins. Obstet Gynecol 1992; 80: 257-261.
20. Danskin, F. H., Neilson, J. P. Twin-to-twin transfusion syndrome: what are appropriate diagnostic criteria? Am J Obstet Gynecol 1989; 161: 365-369.
21. Fesslova, V., Villa, L., Nava, S., Mosca, F., Nicolini, U. Fetal and neonatal echocardiographic findings in twin-twin transfusion syndrome. AmJObstet Gynecol 1998; 179:1056-1062.
22. Scott, F., Evans, N. Distal gangrene in a polycythemic recipient fetus in twin-twin transfusion. Obstet Gynecol 1995; 86: 677-69.
23. Dawkins, R. R., Marshall, T. L., Rogers, M. S. Prenatal gangrene in association with twin-twin transfusion syndrome. Am J Obstet Gynecol 1995; 172: 1055-1057.
24. Bowden, J. B., Hebert, A. A., Rapini, R. P. Dermal hematopoiesis in neonates: report of five cases. J Am Acad Dermatol 1989; 20:1104-1110.
25. Schwartz, J. L., Maniscalco, W. M., Lane, A. T., Currao, W. J. Twin transfusion syndrome causing cutaneous erythro- poiesis. Pediatrics 1984; 74: 527-529.
26. Koenig, J. M., Hunter, D. D., Christensen, R. D. Neutropenia in donor (anemic) twins involved in the twin-twin transfusion syndrome. JPerinatol 1991; 11: 355-358.
27. Pietrantoni, M., Stewart, D. L., Ssemakula, N., etal.Mortality conference: twin-to-twin transfusion. J Pediatr 1998; 132: 1071-1076.
28. Rainey, K. E., DiGeronimo, R. J., Pascual-Baralt, J. Successful long-term peritoneal dialysis in a very low birth weight infant with renal failure secondary to feto-fetal transfusion syndrome. Pediatrics 2000; 106: 849-851.
29. Lopriore, E., Vandenbussche, F. P., Tiersma, E. S., de Beaufort, A. J., de Leeuw, J. R Twin-to-twin transfusion syndrome: new perspectives. JPediatr 1995; 127: 675-680.
30. Pinette, M. G., Pan, Y., Pinette, S. G., Stubblefield, P. G. Treatment of twin-twin transfusion syndrome. Obstet Gynecol 1993; 82: 841-846.
31. Zikulnig, L., Hecher, K., Bregenzer, T., Baz, E., Hackeloer, B. J. Prognostic factors in severe twin-twin transfusion syndrome treated by endoscopic laser surgery. Ultrasound Obstet Gynecol 1999; 14: 380-387.
32. Cordero, L., Landon, M. B. Infant of the diabetic mother. Clin Perinatol 1993; 20: 635-648.
33. Cowett, R. M., Schwartz, R. The infant of the diabetic mother. Pediatr Clin North Am 1982; 29: 1213-1231.
34. Mimouni, F., Miodovnik, M., Siddiqi, T. A., et al. Neonatal polycythemia in infants of insulin-dependent diabetic mothers. Obstet Gynecol 1986; 68: 370-372.
35. Green, D. W., Khoury, J., Mimouni, F. Neonatal hematocrit and maternal glycemic control in insulin-dependent diabetes. JPediatr 1992; 120: 302-305.
36. Stonestreet, B. S., Goldstein, M., Oh, W., Widness, J.A. Effects of prolonged hyperinsulinemia on erythropoiesis in fetal sheep. Am J Physiol 1989; 257: R1199-1204.
37. Perrine, S. P, Greene, M. F., Lee, P D., Cohen, R.A., Faller, D. V Insulin stimulates cord blood erythroid progenitor growth: evidence for an aetiological role in neonatal polycythaemia. BrJHaematol 1986; 64: 503-511.
38. Widness, J. A., Teramo, K. A., Clemons, G. K., et al. Direct relationship of antepartum glucose control and fetal erythropoietin in human type 1 (insulin-dependent) diabetic pregnancy. Diabetologia 1990; 33: 378-383.
39. Widness, J. A., Susa, J. B., Garcia, J. F., et al. Increased ery- thropoiesis and elevated erythropoietin in infants born to diabetic mothers and in hyperinsulinemic rhesus fetuses. J Clin Invest 1981; 67: 637-642.
40. Shannon, K., Davis, J. C., Kitzmiller, J. L., Fulcher, S. A., Koenig, H. M. Erythropoiesis in infants of diabetic mothers. Pediatr Res 1986;20:161-165.
41. Green, D. W., Mimouni, F. Nucleated erythrocytes in healthy infants and in infants of diabetic mothers. J Pediatr 1990; 116:129-31.
42. Green, D. W., Mimouni, F., Khoury, J. Decreased platelet counts in infants of diabetic mothers. Am J Perinatol 1995; 12:102-105.
43. Perrine, S. P, Greene, M. F., Faller, D. V Delay in the fetal globin switch in infants of diabetic mothers. N Engl J Med 1985; 312: 334-338.
44. Bard, H., Prosmanne, J. Relative rates of fetal hemoglobin and adult hemoglobin synthesis in cord blood of infants of insulin-dependent diabetic mothers. Pediatrics 1985;75: 1143-1147.
45. Oppenheimer, E. H., Esterly, J. R. Thrombosis in the newborn: comparison between infants of diabetic and nondiabetic mothers. JPediatr 1965; 67: 549-556.
46. Van Allen, M. I., Jackson, J. C., Knopp, R. H., Cone, R. In utero thrombosis and neonatal gangrene in an infant of a diabetic mother. AmJMed Genet 1989; 33: 323-327.
47. Hathaway, W. E., Mahasandana, C., Makowski, E. L. Cord blood coagulation studies in infants of high-risk pregnant women. Am J Obstet Gynecol 1975; 121:51-57.
48. Stuart, M. J., Elrad, H., Graeber, J. E., et al. Increased synthesis of prostaglandin endoperoxides and platelet hyperfunction in infants of mothers with diabetes mellitus. J Lab Clin Med 1979; 94: 12-26.
49. Stuart, M. J., Sunderji, S. G., Allen, J. B. Decreased prostacyclin production in the infant of the diabetic mother. J Lab Clin Med 1981; 98: 412-416.
50. Easa, D., Coen, R. W. Coagulation studies in infants of diabetic mothers. AmJDis Child 1979; 133: 851-852.
51. Ambrus, C. M., Ambrus, J. L., Courey, N., et al. Inhibitors of fibrinolysis in diabetic children, mothers, and their newborn. Am JHematol 1979;7: 245-254.
52. Fonseca, V.A., Reynolds, T., Fink, L. M. Hyperhomocysteine- mia and microalbuminuria in diabetes. Diabet Care 1998; 21:1028.
53. Shah, D. M. Hypertensive disorders of pregnancy. In Fanaroff, A. A., Martin, R. J., eds. Neonatal-Perinatal Medicine Disease of the Fetus and Infant, Vol. 1. St Louis: Mosby, 2002: 263-276.
54. Manroe, B. L., Weinberg, A. G., Rosenfeld, C. R., Browne, R. Theneonatalbloodcountinhealthanddisease.I.Reference values for neutrophilic cells. JPediatr 1979; 95: 89-98.
55. Engle, W. D., Rosenfeld, C. R. Neutropenia in high-risk neonates. JPediatr 1984; 105: 982-986.
56. Mouzinho, A., Rosenfeld, C. R., Sanchez, P. J., Risser, R. Effect of maternal hypertension on neonatal neutropenia and risk of nosocomial infection. Pediatrics 1992; 90: 430-435.
57. Koenig, J. M., Christensen, R. D. Incidence, neutrophil kinetics, and natural history of neonatal neutropenia associated with maternal hypertension. N Engl JMed 1989; 321: 557-562.
58. Doron, M. W., Makhlouf, R. A., Katz, V. L., Lawson, E. E., Stiles, A. D. Increased incidence of sepsis at birth in neutropenic infants of mothers with preeclampsia. J Pediatr 1994; 125:452-458.
59. Gray, P. H., Rodwell, R. L. Neonatal neutropenia associated with maternal hypertension poses a risk for nosocomial infection. Eur J Pediatr 1999; 158:71-73.
60. Makhlouf, R.A., Doron, M. W., Bose, C. L., Price, W. A., Stiles, A. D. Administration of granulocyte colony-stimulating factor to neutropenic low birth weight infants of mothers with preeclampsia. J Pediatr 1995; 126: 454-456.
61. Brazy, J. E., Grimm, J. K., Little, V. A. Neonatal manifestations of severe maternal hypertension occurring before the thirty-sixth week of pregnancy. J Pediatr 1982; 100:265271.
62. Kurlat, I., Sola, A. Neonatal polycythemia in appropriately grown infants of hypertensive mothers. Acta Paediatr 1992; 81: 662-4.
63. Moore, J. L., Jr, Martin, J. N., Jr. Cancer and pregnancy. Obstet Gyneco lClin North Am 1992; 19: 815-827.
64. Waalen, J. Pregnancy poses tough questions for cancer treatment. J Natl CancerInst 1991; 83:900-902.
65. Doll, D. C., Ringenberg, Q. S., Yarbro, J. W. Management of cancer during pregnancy. Arch Intern Med 1988; 148:2058-2064.
66. Doll, D. C., Ringenberg, Q. S., Yarbro, J. W. Antineoplastic agents and pregnancy. Semin Oncol 1989; 16: 337-346.
67. Zemlickis, D., Klein, J., Moselhy, G., Koren, G. Cisplatin protein binding in pregnancy and the neonatal period. Med Pediatr Oncol 1994; 23: 476-479.
68. Schapira, D.V., Chudley, A. E. Successfulpregnancyfollow-ing continuous treatment with combination chemotherapy beforeconceptionandthroughoutpregnancy.Cancer 1984; 54: 800-803.
69. Glantz, J. C. Reproductive toxicology of alkylating agents. Obstet Gynecol Surv 1994; 49: 709-715.
70. Zemlickis, D., Lishner, M., Degendorfer, P., et al. Fetal outcome after in utero exposure to cancer chemotherapy. Arch Intern Med 1992; 152: 573-576.
71. Caligiuri, M.A., Mayer, R. J. Pregnancy and leukemia. Semin Oncol 1989; 16: 388-396.
72. Buekers, T. E., Lallas, T. A. Chemotherapy in pregnancy. Obstet Gynecol Clin NorthAm 1998; 25: 323-329.
73. Achtari, C., Hohlfeld, P. Cardiotoxic transplacental effect of idarubicin administered during the second trimester of pregnancy. Am J Obstet Gynecol 2000;183:511-512.
74. Aviles, A., Niz, J. Long-term follow-up of children born to mothers with acute leukemia during pregnancy. Med Pedi- atr Oncol 1988; 16: 3-6.
75. Sorosky, J. I., Sood, A. K., Buekers, T. E. The use of chemotherapeuticagentsduringpregnancy.ObstetGynecol ClinNorthAm 1997; 24: 591-599.
76. Aviles, A., Diaz-Maqueo, J. C., Talavera, A., Guzman, R., Garcia, E. L. Growth and development of children of mothers treated with chemotherapy during pregnancy: current sta- tusof43 children. Am JHematol 1991;36: 243-248.
77. Randall, T. National registry seeks scarce data on pregnancy outcomes during chemotherapy. J Am Med Assoc 1993; 269: 323.
78. Mayr, N. A., Wen, B. C., Saw, C. B. Radiation therapy during pregnancy. ObstetGynecolClinNorthAm 1998;25:301-321.
79. Brent, R. L. The effect of embryonic and fetal exposure to x- ray, microwaves, and ultrasound: counseling the pregnant and nonpregnant patient about these risks. Semin Oncol 1989; 16: 347-368.
80. Dildy, G. A. D., Moise, K. J., Jr, Carpenter, R. J., Jr, Klima, T. Maternal malignancy metastatic to the products of conception: a review. Obstet Gynecol Surv 1989; 44: 535-540.
81. Silverman, E. D., Laxer, R. M. Neonatal lupus erythematosus. Rheum Dis Clin North Am 1997; 23: 599-618.
82. Watson, R., Kang, J. E., May, M., et al. Thrombocytopenia in the neonatal lupus syndrome. Arch Dermatol 1988; 124: 560-563.
83. Hariharan, D., Manno, C. S., Seri, I. Neonatal lupus erythematosus with microvascular hemolysis. J Pediatr Hematol Oncol 2000; 22: 351-354.
84. Contractor, S., Hiatt, M., Kosmin, M., Kim, H. C. Neonatal thrombosis with anticardiolipin antibody in baby and mother. Am J Perinatol 1992; 9: 409-410.
85. Brewster, J. A., Shaw, N. J., Farquharson, R. G. Neonatal and pediatric outcome of infants born to mothers with antiphospholipid syndrome. J Perinat Med 1999; 27: 183-187.
86. Tabbutt, S., Griswold, W. R., Ogino, M. T., et al. Multiple thromboses in a premature infant associated with maternal phospholipid antibody syndrome. J Perinatol 1994; 14:6670.
87. Sheridan-Pereira, M., Porreco, R. R, Hays, T., Burke, M. S. Neonatal aortic thrombosis associated with the lupus anticoagulant. Obstet Gynecol 1988; 71: 1016-1018.
88. Fried, P. A. Prenatal exposure to tobacco and marijuana: effects duringpregnancy, infancy, and earlychildhood. Clin Obstet Gynecol 1993; 36: 319-337.
89. Kendrick, J. S., Merritt, R. K. Women and smoking: an update for the 1990s. Am J Obstet Gynecol 1996; 175: 528-535.
90. Bardy, A. H., Seppala, T., Lillsunde, P., etal. Objectivelymea-sured tobacco exposure during pregnancy: neonatal effects and relationtomaternalsmoking.BrJObstet Gynaecol 1993; 100: 721-726.
91. Nilsen, S. T., Sagen, N., Kim, H. C., Bergsjo, P. Smoking, hemoglobin levels, and birth weights in normal pregnancies. Am J Obstet Gynecol 1984; 148: 752-758.
92. Castles, A., Adams, E. K., Melvin, C. L., Kelsch, C., Boulton, M. L. Effects of smoking during pregnancy: five metaanalyses. AmJPrevMed 1999; 16: 208-215.
93. Bureau, M. A., Monette, J., Shapcott, D., et al. Carboxyhe- moglobin concentration in fetal cord blood and in blood of mothers who smoked during labor. Pediatrics 1982; 69: 371-373.
94. Bureau, M. A., Shapcott, D., Berthiaume, Y., et al. Maternal cigarette smoking and fetal oxygen transport: a study of P50, 2, 3-diphosphoglycerate, total hemoglobin, hematocrit, and type F hemoglobin in fetalblood. Pediatrics 1983; 72: 22-26.
95. Varvarigou, A., Beratis, N. G., Makri, M., Vagenakis, A. G. Increased levels and positive correlation between erythropoietin and hemoglobin concentrations in newborn children of mothers who are smokers. J Pediatr 1994;124:480-482.
96. Bili, H., Mamopoulos, M., Tsantali, C., et al. Elevated umbilical erythropoietin levels during labor in newborns of smoking mothers. Am J Perinatol 1996; 13: 8587.
97. Meberg, A., Haga, P., Sande, H., Foss, O. P. Smoking during pregnancy: hematological observations in the newborn. Acta Paediatr Scand 1979; 68: 731-734.
98. D’souza, S. W., Black, P M., Williams, N., Jennison, R. F. Effect of smoking during pregnancy upon the haemato- logical values of cord blood. Br J Obstet Gynaecol 1978;85: 495-499.
99. Mercelina-Roumans, P E., Breukers, R. B., Ubachs, J. M., van Wersch, J. W. Hematological variables in cord blood of neonates of smoking and nonsmoking mothers. J Clin Epidemiol 1996; 49: 449-454.
100. Gruslin, A., Perkins, S. L., Manchanda, R., Fleming, N., Clinch, J. J. Maternal smoking and fetal erythropoietin levels. Obstet Gynecol 2000; 95: 561-564.
101. Jazayeri, A., Tsibris, J. C., Spellacy, W. N. Umbilical cord plasma erythropoietin levels in pregnancies complicated by maternal smoking. Am J Obstet Gynecol 1998; 178: 433-435.
102. Hanion-Lundberg, K. M., Kirby, R. S., Gandhi, S., Broekhuizen, F. F. Nucleated red blood cells in cord blood of singleton term neonates. Am J Obstet Gynecol 1997;176: 1149-1154, 1154-1156.
103. Dollberg, S., Fainaru, O., Mimouni, F. B., et al. Effect of passive smoking in pregnancyon neonatal nucleated red blood cells. Pediatrics 2000; 106: E34.
104. Spinillo, A., Ometto, A., Stronati, M., et al. Epidemiologic association between maternal smoking during pregnancy and intracranial hemorrhage in preterm infants. J Pediatr 1995; 127: 472-478.
105. Mercelina-Roumans, P E., Ubachs, J. M., van Wersch, J. W. Hemostasis in newborns of smoking and nonsmoking mothers. Am JObstetGynecol 1997; 176: 662-666.
106. Mountain, K. R., Hirsh, J., Gallus, A. S. Neonatalcoagulation defect due to anticonvulsant drug treatment in pregnancy. Lancet 1970; 1:265-268.
107. Hey, E. Effect of maternal anticonvulsant treatment on neonatal blood coagulation. Arch Dis Child Fetal Neonatal Ed 1999; 81: F208-F210.
108. Howe, A. M., Oakes, D. J., Woodman, P. D., Webster, W. S. Prothrombin and PIVKA-II levels in cord blood from newborn exposed to anticonvulsants during pregnancy. Epilepsia 1999; 40: 980-984.
109. Bleyer, W. A., Au, W. Y. A., Lange, W. A., Raisz, L. G. Studies on the detection of adverse drug reactions in the newborn. JAm MedAssoc 1970; 213: 2049-2053.
110. Stuart, M. J., Gross, S. J., Elrad, H., Graeber, J. E. Effects of acetylsalicylic-acid ingestion on maternal and neonatal hemostasis. NEnglJMed 1982; 307: 909-912.
111. Norton, M. E., Merrill, J., Cooper, B. A., Kuller, J. A., Clyman, R. I. Neonatal complications after the administration of indomethacin for preterm labor. N Engl J Med 1993; 329: 1602-1607.
112. Lukens, J. N. Neonatal haematological abnormalities associated with maternal disease. Clin Haematol 1978; 7:155-173.
113. Greinacher, A., Eckhardt, T., Mussmann, J., Mueller- Eckhardt, C. Pregnancy complicated by heparin associated thrombocytopenia:managementbyaprospectivelyinvitro selectedheparinoid(Org10172). Thromb Res 1993;71:123-126.
114. Beutler, E. Glucose-6-phosphate dehydrogenase: newper- spectives. Blood 1989; 73: 1397-1401.
115. Barak, M., Cohen, A., Herschkowitz, S. Total leukocyte and neutrophil count changes associated with antenatal betamethasone administration in premature infants. Acta Paediatr 1992; 81: 760-763.
116. Anday, E. K., Harris, M. C. Leukemoid reaction associated with antenatal dexamethasone administration. J Pediatr 1982; 101:614-616.
117. Calhoun, D. A., Rosa, C., Christensen, R. D. Transplacental passage of recombinant human granulocyte colony- stimulating factor in women with an imminent preterm delivery. AmJObstet Gynecol 1996; 174:1306-1311.
118. Stoltzfus, R. J. Iron-deficiency anemia: reexamining the nature and magnitude of the public health problem. Summary: implications for research and programs. JNutr 2001; 131: 697S-700S, 700S-701S.
119. Looker, A. C., Dallman, P. R., Carroll, M. D., Gunter, E. W., Johnson, C. Prevalence of iron deficiency in the United States. JAmMedAssoc 1997; 277: 973-976.
120. Strain, J. J., Thompson, K. A., Barker, M. E., Carville, D. G. Iron sufficiencyin the population of northern Ireland: estimates from blood measurements. Br J Nutr 1990; 64: 219-224.
121. Beard, J. L. Effectiveness and strategies of iron supplementation during pregnancy. Am J Clin Nutr 2000; 71: 1288S-1294S.
122. Choi, J. W., Kim, C. S., Pai, S. H. Erythropoietic activity and soluble transferrin receptor level in neonates and maternal blood. Acta Paediatr 2000; 89: 675-679.
123. Brugnara, C., Zurakowski, D., DiCanzio, J., Boyd, T., Platt, O. Reticulocyte hemoglobin content to diagnose iron defi- ciencyinchildren. JAmMedAssoc 1999; 281: 2225-2230.
124. Milman, N., Bergholt, T., Byg, K. E., Eriksen, L., Graudal, N. Iron status and iron balance during pregnancy: a critical reappraisal of iron supplementation. Acta Obstet Gynecol Scand 1999; 78: 749-757.
125. Werner, E. J., Stockman, J. A., 3rd. Red cell disturbances in the feto-maternalunit. SeminPerinatol 1983; 7:139-158.
126. Allen, L. H. Anemia and iron deficiency: effects on preg- nancyoutcome. Am J ClinNutr 2000; 71:1280S-4S.
127. Harthoon-Lasthuizen, E. J., Lindemans, J., Langenhuijsen, M. M. Does iron-deficient erythropoiesis in pregnancy influence fetaliron supply? Acta Obstet Gynecol Scand 2001; 80: 392-386.
128. Barton, D. P, Joy, M. T., Lappin, T. R., et al. Maternal erythropoietin in singleton pregnancies: a randomized trial on the effect of oral hematinic supplementation. Am J Obstet Gynecol 1994; 170: 896-901.
129. Steer, P J. Maternal hemoglobin concentration and birth weight. Am J Clin Nutr 2000; 71: 1285S-1287S.
130. Scholl, T. O., Hediger, M. L., Fischer, R. L., Shearer, J. W. Ane- miavs iron deficiency: increased riskofpreterm deliveryin a prospective study. Am J Clin Nutr 1992;55: 985-988.
131. Preziosi, P, Prual, A., Galan, P, et al. Effect of iron supplementation on the iron status of pregnant women: consequences fornewborns. AmJClin Nutr 1997; 66:1178-1182.
132. Johnston, R. B., Jr. Folic acid: new dimensions of an old friendship. AdvPediatr 1997; 44:231-261.
133. Chanarin, I. Folate and cobalamine. Clin Haematol 1985; 14: 629-641.
134. Rosenblatt, D. S., Whitehead, V. M. Cobalamine and folate deficiency: acquired and hereditary disorders in children. SeminHematol 1999; 36:19-34.
135. American Academy of Pediatrics. Committee on Genetics. Folic acid for the prevention of neural tube defects. Pediatrics 1999; 104: 325-327.
136. Ek, J. Plasma and red cell folate values in newborn infants and their mothers in relation to gestational age. J Pediatr 1980; 97: 288-192.
137. Kamen, B. A., Caston, J. D. Purification of folate binding factor in normal umbilical cord serum. Proc Natl Acad Sci USA 1975; 72: 4261-4264.
138. Pritchard, J. A., Scott, D. E., Whalley, P. J., Haling, R. F., Jr. Infants of mothers with megaloblastic anemia due to folate deficiency. J Am Med Assoc 1970; 211:1982-1984.
139. Bjorke Monsen, A. L., Ueland, P. M., Vollset, S. E., et al. Determinants of cobalamin status in newborns. Pediatrics 2001; 108: 624-630.
140. Whitehead, V M., Rosenblatt, D. S., Cooper, B. A. Megaloblastic anemia. In Nathan, D. G., Orkin, S.H., eds. Hematology of Infancy and Childhood, Vol.1. Philadelphia: W. B. Saunders, 1998; 385-422.
141. Lampkin, B. C., Shore, N. A., Chadwick, D. Megaloblastic anemia of infancy secondary to maternal pernicious anemia. NEngl JMed 1966; 274: 1168-1171.
142. American Academy of Pediatrics. Toxoplasma gondii infections. In Pickering, L. K., ed. Red Book: 2003 Report of the Committee on Infectious Disease. 26th edn. Elk Grove Village, IL: American Academyof Pediatrics, 2003; 189-781.
143. Hohlfeld, P, Daffos, F., Costa, J. M., et al. Prenatal diagnosis of congenital toxoplasmosis with a polymerase-chain- reaction teston amniotic fluid. NEngl JMed 1994;331:695-699.
144. Remington, J. S., McLeod, R., Thulliez, P, Desmonts, G. Toxoplasmosis. In Remington, J. S., Klein, J. O., eds. Infectious Diseaseofthe Fetusand Newborn. Philadelphia: W. B. Saunders Company, 2001; 205-346.
145. Beazley, D. M., Egerman, R. S. Toxoplasmosis. Semin Perinatal 1998; 22:332-338.
146. Guerina, N. G., Hsu, H. W., Meissner, H. C., et al. Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. The New England Regional Toxoplasma Working Group. NEnglJMed 1994;330:1858-1863.
147. Couvreur, J., Desmonts, G., Girre, J. Y. Congenital toxoplasmosis in twins: a series of 14 pairs of twins: absence of infection in one twin in two pairs. J Pediatr 1976; 89: 235-240.
148. Pratlong, F., Boulot, R Fetal diagnosis of toxoplasmosis in 190 women infected during pregnancy. Prenat Diagn 1995; 14:191-198.
149. Romand, S., Wallon, M., Franck, J., et al. Prenatal diagnosis using polymerase chain reaction on amniotic fluid for congenital toxoplasmosis. Obstet Gynecol 2001; 97: 296-300.
150. American Academy of Pediatrics. Toxoplasma gondii infections. In Pickering, L. K., ed. Red Book: 2003 Report of the Committee on Infectious Disease. 26th edn. Elk Grove Village, IL: American Academy of Pediatrics; 2003: 631-635.
151. Koskiniemi, M., Lappalainen, M., Hedman, K. Toxoplamo-sis needs evaluation. AmJDis Child 1989; 143:724-728.
152. Alford, C. A., Jr, Stagno, S., Reynolds, D. W. Congenital toxoplasmosis: clinical, laboratory, and therapeutic considerations, with special reference to subclinical disease. Bull N YAcad Med 1974; 50:160-181.
153. Barron, S. D., Pass, R. F. Infectious causes of hydrops fetalis. Semin Perinatol 1995; 19: 493-501.
154. Hohlfeld, P, Forestier, F., Kaplan, C., Tissot, J. D., Daffos, F. Fetal thrombocytopenia: a retrospective survey of 5, 194 fetal blood samplings. Blood 1994; 84: 1851-1856.
155. Hohlfeld, P, Forestier, F., Marion, S., et al. Toxoplasma gondii infection during pregnancy: T lymphocyte subpopulations in mothers and fetuses. Pediatr Infect Dis J 1990; 9: 878-881.
156. Ingall, D., Sanchez, P J., Syphilis. In Remington, J. W., Klein, J. O., eds. Infectious Diseases of the Fetus and Newborn Infant. Philadelphia: W. B. Saunders, 2001; 643-681.
157. Hurtig, A. K., Nicoll, A., Carne, C., et al. Syphilis in pregnant women and their children in the United Kingdom: results from national clinician reporting surveys 1994-7. Br Med J 1998; 317:1617-1619.
158. Riedner, G., Dehne, K. L., Gromyko, A. Recent declines in reported syphilis rates in eastern Europe and central Asia: are the epidemics over? SexTransm Infect 2000; 76:363-365.
159. Southwick, K. L., Blanco, S., Santander, A., et al. Maternal and congenital syphilis in Bolivia, 1996: prevalence and risk factors. Bull WorldHealth Organ 2001; 79:33-42.
160. Ndumbe, P. M., Andela, A., Nkemnkeng-Asong, J., Watonsi, E., Nyambi, P. Prevalence of infections affecting the child among pregnant women in Yaounde, Cameroon. Med Microbiol Immunol(Berl) 1992; 181:127-130.
161. How, J. H., Bowditch, J. D. Syphilis in pregnancy: experience from a rural aboriginal community. AustNZ J Obstet Gynaecol 1994; 34: 383-389.
162. Sanchez, P J., Wendel, G. D. Syphilis in pregnancy Clin Peri-natol 1997; 24: 71-90.
163. American Academy of Pediatrics. Syphilis. In Pickering, L. K., ed. Red Book: 2000 Report Of the Committee on Infectious Diseases. Elk Grove, IL: American Academy of Pediatrics, 2000; 547-559.
164. Chhabra, R. S., Brion, L. P, Castro, M., Freundlich, L., Glaser, J. H. Comparison of maternal sera, cord blood, and neonatal sera for detecting presumptive congenital syphilis: relationship with maternal treatment. Pediatrics 1993; 91: 8891.
165. Whitaker, J. A., Sartain, P, Shaheedy, M. D. Hematologic aspects of congenital syphilis. JPediatr 1965; 66: 629.
166. Freiman, I., Super, M. Thrombocytopenia and congenital syphilis in South African Bantu infants. ArchDis Child 1965; 41: 87-90.
167. Pohl, M., Niemeyer, C. M., Hentschel, R., et al. Haemophagocytosis in earlycongenital syphilis. EurJPedi- atr 1999; 158: 553-555.
168. Brown, H. L., Abernathy, M. P Cytomegalovirus infection. Semin Perinatol 1998; 22: 260-266.
169. Nelson, C. T., Demmler, G. J. Cytomegalovirus infection in the pregnant mother, fetus, and newborn infant. Clin Peri- natol 1997; 24:151-160.
170. Stagno, S. Cytomegalovirus. In Remington, J. S., Klein, J. O., eds. Infectious Diseases of the Fetus and Newborn Infant. Philadelphia: W. B. Saunders, 2001; 389-424.
171. Boppana, S. B., Rivera, L. B., Fowler, K. B., Mach, M., Britt, W. J. Intrauterine transmission of cytomegalovirus to infants of womenwith preconceptional immunity. NEngl J Med 2001; 344:1366-1371.
172. Adler, S. R Transfusion-acquired CMV infection in premature infants. Transfusion 1989; 29: 278-290.
173. Fowler, K. B., Stagno, S., Pass, R. F., et al. The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N Engl J Med 1992; 326: 663-667.
174. Boppana, S. B., Fowler, K. B., Britt, W. J., Stagno, S., Pass, R. F. Symptomatic congenital cytomegalovirus infection in infants born to mothers with preexisting immunity to cytomegalovirus. Pediatrics 1999; 104:55-60.
175. American Academy of Pediatrics. Cytomegalovirus infection. In Pickering. L. K., ed. Red Book: 2003 Report of the Committee on Infectious Disease. 26th edn. Elk Grove Village, IL: American Academy of Pediatrics, 2003; 259-263.
176. Epps, R. E., Pittelkow, M. R., Su, W. P. TORCH syndrome. Semin Dermatol 1995; 14: 179-186.
177. Fowler, K. B., McCollister, F. P, Dahle, A. J., et al. Progressive and fluctuating sensorineural hearing loss in children with asymptomatic congenital cytomegalovirus infection. JPediatr 1997; 130: 624-630.
178. Weiner, C. P. The elusive search for fetal infection: changing the gold standards. Obstet Gynecol Clin North Am 1997; 24: 19-32.
179. Hagay, Z. J., Biran, G., Ornoy, A., Reece, E. A. Congenital cytomegalovirus infection: a long-standing problem still seeking a solution. Am J Obstet Gynecol 1996; 174:241-245.
180. Gouarin, S., Palmer, P., Cointe, D., etal. Congenital HCMV infection: a collaborative and comparative study of virus detection in amniotic fluid by culture and by PCR. J Clin Virol 2001;21:47-55.
181. Barbi, M., Binda, S., Primache, V., Novelli, C. Cytomegalovirus in peripheral blood leukocytes of infants with congenital or postnatal infection. Pediatr Infect Dis J 1996; 15: 898-903.
182. Arav-Boger, R., Reif, S., Bujanover, Y. Portal vein thrombosis caused by protein C and protein S deficiency associated with cytomegalovirus infection. J Pediatr 1995; 126: 586-588.
183. Hathaway, W. E., Mull, M. M., Pechet, G. S. Disseminated intravascular coagulation in the newborn. Pediatrics 1969; 43: 233-240.
184. Mizutani, K., Azuma, E., Komada, Y., et al. An infantile case of cytomegalovirus induced idiopathic thrombocytopenic purpura with predominant proliferation of CD10 positive lymphoblast in bone marrow. Acta Paediatr Jpn 1995; 37: 71-74.
185. Crapnell, K., Zanjani, E. D., Chaudhuri, A., et al. In vitro infectionofmegakaryocytesandtheirprecursorsbyhuman cytomegalovirus. Blood 2000; 95: 487-493.
186. Hoekelman, R. A., Anderson, V. M. Congenital thrombocytopenia, hepatosplenomegaly, and growth retardation: a clinicopathologic conference. Am J Dis Child 1982; 136: 258-264.
187. Liesner, R. J. Non-immune neonatal anemias. In Lilley- man, J. S., Hann, I. M., Blanchette, V. S., eds. Pediatric Hematology. London: Churchill Livingstone, 1999; 185-202.
188. Murray, J. C., Bernini, J. C., Bijou, H. L., et al. Infantile cytomegalovirus-associated autoimmune hemolytic anemia. J PediatrHematol Oncol 2001; 23:318-320.
189. Maciejewski, J. P, Bruening, E. E., Donahue, R. E., et al. Infection of hematopoietic progenitor cells by human cytomegalovirus. Blood 1992; 80:170-178.
190. Cole, F. S. Viral infections of the fetus and newborn. In H. William Taeusch, RobertaA. Ballard, eds. Avery’s Diseases of the Newborn. 7th edn. 1998, W. B. Saunders Co., Philadelphia, 467-489.
191. Ivarsson, S. A., Ljung, R. Neutropenia and congenital cytomegalovirus infection. Pediatr Infect Dis J 1988; 7:436-437.
192. Cooper, L. Z., Charles, A., Alford, J. Rubella. In Remington, J. S., Klein, J. O., eds. Infectious Diseases of the Fetus and Newborn Infant, Vol. 1. Philadelphia: W. B. Saunders, 2001; 347-388.
193. Freij, B. J., South, M. A., Sever, J. L. Maternal rubella and the congenital rubella syndrome. Clin Perinatol 1988; 15: 247-257.
194. Robinson, J., Lemay, M., Vaudry, W. L. Congenital rubella after anticipated maternal immunity: two cases and a review of the literature. Pediatr Infect Dis J 1994; 13: 812-815.
195. Barfield, W., Gardner, R., Lett, S., Johnsen, C. Congenital rubella reinfection in a mother with anti-cardiolipin and anti-platelet antibodies. Pediatr Infect Dis J 1997; 16: 249-251.
196. American Academy of Pediatrics. Rubella. In Pickering, L. K., ed. Red Book: 2003 Report of the Committee on Infectious Disease. 26th edn. Elk Grove Village, IL: American Academyof Pediatrics; 2003: 536-541.
197. Brough, A. J., Jones, D., Page, R. H., Mizukami, I. Dermal erythropoiesis in neonatal infants: a manifestation of intra-uterine viral disease. Pediatrics 1967; 40: 627-635.
198. Thomas, H. I., Morgan-Capner, P., Cradock-Watson, J. E., et al. Slow maturation of IgG1 avidity and persistence of specific IgM in congenital rubella: implications for diagnosis and immunopathology. J Med Virol 1993; 41: 196-200.
199. Bosma, T. J., Corbett, K. M., Eckstein, M. B., etal. Use of pCR for prenatal and postnatal diagnosis of congenital rubella. J Clin Microbiol 1995; 33: 2881-2887.
200. Janner, D. Growth retardation, congenital heart disease and thrombocytopenia in a newborn infant. Pediatr Infect Dis J 1991; 10: 874-877.
201. Franklin, S. L., Kelley, R. Congenital rubella and interstitial pneumonitis. Clin Pediatr (Phila) 2001; 40: 101-103.
202. Zinkham, W. H., Medearis, D. N., Jr, Osborn, J. E. Blood and bone-marrow findings in congenital rubella. JPediatr 1967; 71:512-524.
203. Bayer, W. L., Sherman, F. E., Michaels, R. H., Szeto, I. L., Lewis, J. H. Purpura in congenital and acquired rubella. N Engl J Med 1965; 273:1362-1366.
204. Cooper, L. Z., Green, R. H., Krugman, S., Giles, J. P., Mirick, G. S. Neonatal thrombocytopenic purpura and other manifestations of rubella contracted in utero. Am J Dis Child 1965; 110:416-427.
205. Rausen, A. R., Richter, P, Tallal, L., Cooper, L. Z. Hematologic effectsofintrauterine rubella. J Am Med Assoc 1967; 199:7578.
206. Lafer, C. Z., Morrison, A. N. Thrombocytopenic purpura progressing to transient hypoplastic anemia in a newborn with rubella syndrome. Pediatrics 1966; 38: 499-501.
207. Scott, L. L., Hollier, L. M., Dias, K. Perinatal herpesvirus infections: herpes simplex, varicella, and cytomegalovirus. Infect Dis Clin North Am 1997; 11: 27-53.
208. Arvin, A. M., Whitley, R.J. Herpes simplexviralinfections. In Remington, J. S., Klein, J. O., eds. Infectious Diseases of the Fetus and Newborn Infant. Philadelphia: W. B. Saunders, 2001; 425-446.
209. Whitley, R. J., Lakeman, F. Herpes simplex virus infections of the central nervous system: therapeutic and diagnostic considerations. Clin Infect Dis 1995; 20: 414-420.
210. Kohl, S. Neonatal herpes simplexvirus infection. Clin Peri- natol 1997; 24:129-150.
211. Douglas, J., Schmidt, O., Corey, L. Acquisition of neonatal HSV-1 infection from a paternal source contact. J Pediatr 1983; 103: 908-910.
212. Kimberlin, D. W., Lakeman, F. D., Arvin, A. M., et al. Application of the polymerase chain reaction to the diagnosis and managementof neonatalherpessimplexvirusdisease. National Institute of allergyand Infectious Diseases Collab- orative Antiviral Study Group. J Infect Dis 1996; 174: 1162-1167.
213. Shershow, L. W., Ekert, H., Swanson, V L., Wright, H.T. Jr, Gilchrist, G. S. Intravascular coagulation ingeneralizedher- pes simplex infection of the newborn. Acta Paediatr Scand 1969; 58: 535-539.
214. Ekert, H. Coagulationabnormalitiesingeneralisedherpes- simplex infection of newborn. Lancet 1970; 2: 775-776.
215. Miller, D. R., Hanshaw, J. B., O’Leary, D. S., Hnilicka, J. V Fatal disseminated herpes simplexvirus infection and hemorrhage in the neonate: coagulation studies in a case and a review. J Pediatr 1970; 76:409-415.
216. Cherry, J. D., Enteroviruses. In Remington, J. S., Klein, J. O., eds. Infectious Diseases of the Fetus and Newborn Infant. Philadelphia: W. B. Saunders, 2001; 477-518.
217. Lake, A. M., Lauer, B. A., Clark, J. C., Wesenberg, R. L., McIntosh, K. Enterovirus infections in neonates. J Pediatr 1976; 89:787-791.
218. Abzug, M. J., Levin, M. J., Rotbart, H. A. Profile of enterovirus disease in the first two weeks of life. Pediatr Infect Dis J 1993; 12: 820-824.
219. Abzug, M. J., Loeffelholz, M., Rotbart, H. A. Diagnosis of neonatal enterovirus infection by polymerase chain reaction. JPediatr 1995; 126: 447-450.
220. Abzug, M. J. Prognosis for neonates with enterovirus hepatitis and coagulopathy. Pediatr Infect Dis J 2001; 20: 758-763.
221. Modlin, J. F. Fatal echovirus 11 disease in premature neonates. Pediatrics 1980; 66: 775-780.
222. Abzug, M. J., Johnson, S. M. Catastrophic intracranialhem- orrhage complicating perinatal viral infections. Pediatr Infect DisJ 2000; 19: 556-559.
223. Brown, K. E., Anderson, S. M., Young, N. S. Erythrocyte P antigen: cellular receptor forB19 parvovirus. Science 1993; 262:114-117.
224. American Academy of Pediatrics. Parvovirus B19. In Pickering, L. K., ed. Red Book: 2003 Report Of the Committee on Infectious Disease. 26thedn. Elk Grove Village, IL: American Academyof pediatrics, 2003; 459-462.
225. Brown, K. E., Young, N.S. Parvovirus B19in human disease. Annu Rev Med 1997; 48: 59-67.
226. Harger, J. H., Adler, S. P, Koch, W. C., Harger, G. F. Prospective evaluation of 618 pregnant women exposed to parvovirus B19: risks and symptoms. Obstet Gynecol 1998; 91: 413-420.
227. Gratacos, E., Torres, P J., Vidal, J., et al. The incidence of human parvovirus B19 infection during pregnancy and its impact on perinatal outcome. JInfect Dis 1995; 171:1360-1363.
228. Skjoldebrand-Sparre, L., Fridell, E., Nyman, M., Wahren, B. A prospective study of antibodies against parvovirus B19 in pregnancy. Acta Obstet Gynecol Scand 1996; 75: 336-339.
229. Gay, N. J., Hesketh, L. M., Cohen, B. J., et al. Age specific antibody prevalence to parvovirus B19: how many women are infected in pregnancy? Commun DisRep CDRRev 1994; 4: R104-R107.
230. Rodis, J. F., Quinn, D. L., Gary, G. W., Jr, et al. Management and outcomes of pregnancies complicated by human B19 parvovirus infection: a prospective study. Am J Obstet Gynecol 1990; 163:1168-1171.
231. Miller, E., Fairley, C. K., Cohen, B. J., Seng, C. Immediate and long term outcome of human parvovirus B19 infection in pregnancy. Br J Obstet Gynaecol 1998; 105:174-178.
232. Rodis, J. F, Rodner, C., Hansen, A. A., et al. Longterm outcome of children following maternal human parvovirus B19 infection. Obstet Gynecol 1998; 91: 125-128.
233. Markenson, G. R., Yancey, M. K. Parvovirus B19 infections in pregnancy. Semin Perinatol 1998; 22:309-317.
234. Koch, W. C., Harger, J. H., Barnstein, B., Adler, S. P Serologic and virologic evidence for frequent intrauterine transmission of human parvovirus B19 with a primary maternal infection during pregnancy. Pediatr Infect Dis J 1998; 17: 489-494.
235. Gallagher, P. G., Forget, B. G., Lux, S. E. Disorders of the erythrocyte membrane. In Nathan, D. G., Orkin, S. H., eds. Nathan and Oski’s Hematology of Infancy and Childhood, Vol. 1. Philadelphia: W. B. Saunders, 1998; 544-664.
236. Katz, V. L., Chescheir, N. C., Bethea, M. Hydrops fetalis from B19 parvovirus infection. J Perinatol 1990; 10: 366-368.
237. Giannakopoulou, C., Hatzidaki, E., Giannakopoulos, K., et al. Congenital infection by human parvovirus B19 ascites-anaemia. Clin Exp Obstet Gynecol 1998; 25:92-93.
238. Hadi, H. A., Easley, K. O., Finley, J. Clinical significance of human parvovirus B19 infection in pregnancy. Am J Perinatol 1994; 11:398-400.
239. Brown, K. E., Green, S. W., Antunez de Mayolo, J., et al. Congenital anaemia after transplacental B19 parvovirus infection. Lancet 1994; 343: 895-896.
240. Smoleniec, J. S., Pillai, M. Management of fetal hydrops associated with parvovirus B19 infection. Br J Obstet Gynaecol 1994; 101:1079-1081.
241. Bahl, P. S., Davies, N. J. Spontaneous resolution of nonimmune hydrops fetalis secondary to transplacental parvovirus B19 infection. Ultrasound Obstet Gynecol 1996; 7: 55-57.
242. Faure, J. M., Giacalone, P L., Deschamps, F, Boulot, P Nonimmune hydrops fetalis caused byintrauterine human parvovirus B19 infection: a case of spontaneous reversal in utero. Fetal Diagn Ther 1997; 12:66-67.
243. Fairley, C. K., Smoleniec, J. S., Caul, O. E., Miller, E. Observational study of effect of intrauterine transfusions on outcome of fetal hydrops after parvovirus B19 infection. Lancet 1995; 346:1335-1337.
244. Forestier, F, Tissot, J. D., Vial, Y., Daffos, F., Hohlfeld, P Haematological parameters of parvovirus B19 infection in 13 fetuses with hydrops foetalis. Br J Haematol 1999; 104: 925-957.
245. Brown, K. E., Green, S. W., Antunez de Mayolo, J., et al. Congenital anaemia after transplacental B19 parvovirus infection. Lancet 1994; 343: 895-896.
246. Kurtzman, G., Frickhof en, N., Kimball, J., etal. Pure red-cell aplasia of 10 years’ duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy. NEngl J Med 1989; 321:519-523.
247. Rates of mother-to-child transmission of HIV-1 in Africa, America, and Europe: results from 13 perinatal studies. The Working Group on Mother-To-Child Transmission of HIV. JAcquir Immune Defic Syndr Hum Retrovirol 1995; 8: 506-510.
248. Owen, W. C., Werner, E. J. Hematologic problems. In Zeich- ner, S. L., Read, J. S., eds. Handbook of Pediatric HIV Care. Philadelphia: Lippincott Williams & Wilkins, 1999; 403-413.
249. Connor, E. M., Sperling, R. S., Gelber, R., et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 1994; 331:1173-1180.
250. Sperling, R. S., Stratton, P., O’sullivan, M. J., etal. A survey of zidovudine use in pregnant women with human immunodeficiency virus infection. NEngl JMed 1992; 326:857-861.
251. Mandelbrot, L., Schlienger, I., Bongain, A., et al. Thrombocytopenia in pregnant women infected with human immunodeficiency virus: maternal and neonatal outcome. Am J Obstet Gynecol 1994; 171: 252-257.
252. Boucher, F. D., Modlin, J. F, Weller, S., etal.Phase I evaluation of zidovudine administered to infants exposed at birth to the human immunodeficiency virus. J Pediatr 1993; 122: 137-144.
253. Kuritzkes, D. R. Neuropenia, neurophil dysfunction, and bacterial infection in patients with human immunodeficiency virus disease: the role of granulocyte colony- stimulating factor. Clin Infect Dis 2000; 30: 256-260.
254. Goldberg, G. N., Fulginiti, V. A., Ray, C. G., et al. In utero Epstein-Barr virus (infectious mononucleosis) infection. J Am Med Assoc 1981; 246:1579-1581.
255. Joncas, J. H., Alfieri, C., Leyritz-Wills, M., et al. Simultaneous congenital infection with Epstein-Barr virus and cytomegalovirus. NEngl JMed 1981; 304:1399-1403.
256. Horwitz, C. A., McClain, K., Henle, W., Henle, G., Anderson, S. J. Fatal illness in a 2-week-old infant: diagnosis by detectionof epstein-Barrvirusgenomesfromalymphnode biopsy. J Pediatr 1983; 103: 752-755.
257. Fleisher, G., Bologonese, R. Infectious mononucleosis during gestation: report of three women and their infants studied prospectively. Pediatr Infect Dis 1984; 3: 308-311.
258. Le, C. T., Chang, R. S., Lipson, M. H. Epstein-Barr virus infections during pregnancy: a prospective study and review of the literature. Am J Dis Child 1983; 137: 466-468.
259. Fleisher, G., Bologonese, R. Epstein-Barr virus infections in pregnancy: a prospective study. J Pediatr 1984; 104: 374-379.
260. Oski, F. A., Naiman, J. L. Anemia in the neonatal period. In Oski, F. A., Naiman, J. L., eds. Hematologic Problems in the Newborn, Vol. 1. Philadelphia: W. B. Saunders, 1982; 56-86.
261. Lucio, L. Glucose-6-phosphate dehydrogenase deficiency and haemolytic anemia. In Nathan, D. G., Orkin, S. H., Gins- burg, D., Look, A. T., eds. Nathan and Oski’s Hematology of Infancy and Childhood, 6th edn. Philadelphia: W. B. Saunders, 2003; 721-742.